# Ligand (LGND) — Earnings

LGND · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lgnd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.37 |
| EPS estimate | $1.95 |
| EPS surprise | +21.48% |
| Revenue surprise | +4.64% |
| Revenue | $63.7M |
| Revenue estimate | $60.9M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/886163/000088616326000044/lgnd-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/59c691cb-3eb8-e646-ba17-0f12021e415f.html) |

Ligand reported Q2 2026 results on August 6, 2026. Earnings per share were $2.37, ahead of the $1.95 estimate by 21.48%. Revenue was $63.7 million against a $60.9 million consensus. Compared with Q2 2025, EPS rose about 48% from $1.60 and revenue rose about 34% from $47.6 million.

Annual EPS in the table moved from $2.04 in 2022 to $6.10 in 2023, eased to $5.71 in 2024 and climbed to $8.04 in 2025. Revenue took a different path, falling from $219.6 million in 2022 to $131.4 million in 2023 before rising to $268.1 million in 2025. Q3 2025 holds the highs here, at $3.09 per share and $115.5 million in revenue. The first half of 2026 totals $4.00 per share, about 37% more than a year earlier. Over the last 20 quarters, Ligand beat the EPS estimate 16 times. The most recent miss was Q1 2026, at 10.23% below.

Ligand has reported Q3 between November 6 and November 9 in each of the past five years. That points to early November 2026 for the next report. It will show how Q3 compares with the $3.09 per share and $115.5 million in revenue from Q3 2025.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $1.95 | $2.37 | 21.48% | $60.9M | $63.7M |
| Q1 2026 | May 7, 2026 | $1.82 | $1.63 | -10.23% | $58.7M | $51.7M |
| Q4 2025 | Feb 26, 2026 | $1.50 | $2.02 | 34.93% | $55.6M | $59.7M |
| Q3 2025 | Nov 6, 2025 | $1.93 | $3.09 | 60.24% | $58.7M | $115.5M |
| Q2 2025 | Aug 7, 2025 | $1.42 | $1.60 | 12.57% | $43.9M | $47.6M |
| Q1 2025 | May 8, 2025 | $1.21 | $1.33 | 9.76% | $38.7M | $45.3M |
| Q4 2024 | Feb 27, 2025 | $1.19 | $1.27 | 6.72% | $39.0M | $42.8M |
| Q3 2024 | Nov 7, 2024 | $1.35 | $1.84 | 36.59% | $40.6M | $51.8M |
| Q2 2024 | Aug 6, 2024 | $1.06 | $1.40 | 32.55% | $33.0M | $41.5M |
| Q1 2024 | May 7, 2024 | $0.83 | $1.20 | 43.88% | $27.9M | $31.0M |
| Q4 2023 | Feb 27, 2024 | $0.66 | $1.38 | 108.84% | $25.6M | $28.1M |
| Q3 2023 | Nov 8, 2023 | $0.62 | $1.02 | 64.52% | $27.2M | $32.9M |
| Q2 2023 | Aug 8, 2023 | $0.64 | $1.42 | 123.27% | $24.7M | $26.4M |
| Q1 2023 | May 4, 2023 | $0.89 | $2.28 | 155.03% | $33.5M | $44.0M |
| Q4 2022 | Feb 22, 2023 | $0.77 | $0.75 | -2.96% | $44.1M | $50.4M |
| Q3 2022 | Nov 7, 2022 | $0.28 | $0.26 | -5.09% | $38.3M | $66.1M |
| Q2 2022 | Aug 8, 2022 | $0.28 | $0.66 | 139.50% | $37.7M | $57.4M |
| Q1 2022 | May 4, 2022 | $0.42 | $0.37 | -11.45% | $34.2M | $45.7M |
| Q4 2021 | Feb 17, 2022 | $0.88 | $1.16 | 31.39% | $65.1M | $72.5M |
| Q3 2021 | Nov 9, 2021 | $0.68 | $1.02 | 49.40% | $58.7M | $64.8M |

## Frequently Asked Questions

### When did Ligand (LGND) last report earnings?

Ligand last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did LGND beat earnings estimates?

Yes. Ligand reported EPS of $2.37 for Q2 2026 against a $1.95 estimate — a 21.48% beat.

### How much revenue did LGND report last quarter?

Ligand reported $63.7M in revenue for Q2 2026, against a consensus estimate of $60.9M.

## Similar Stocks

- [ANIP](https://www.lighthorse.io/tickers/anip) — ANI Pharmaceuticals, Inc. - Common Stock
- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).